Literature DB >> 2505078

Cost effectiveness as a criterion for Medicare coverage.

A Leaf1.   

Abstract

Mesh：

Year:  1989        PMID： 2505078     DOI： 10.1056/NEJM198909283211311

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Clinical economics: a method for prospective health resource data collection.

Authors:  C Copley-Merriman; L Egbuonu-Davis; J G Kotsanos; P Conforti; T Franson; G Gordon
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 2.  The generalisability of pharmacoeconomic studies.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 3.  The economics and cost-effectiveness of critical care medicine.

Authors:  D B Chalfin; I L Cohen; J Lambrinos
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

4.  The review process used by US health care plans to evaluate new medical technology for coverage.

Authors:  C A Steiner; N R Powe; G F Anderson; A Das
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

5.  Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA?

Authors:  James D Chambers
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

Review 6.  Enlightened individual choice vs the public's health: rational prevention from whose perspective?

Authors:  L Goldman
Journal:  J Gen Intern Med       Date:  1995-03       Impact factor: 5.128

7.  Economic evaluation of long-term management strategies for erosive oesophagitis.

Authors:  R Goeree; B O'Brien; R Hunt; G Blackhouse; A Willan; J Watson
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.